Clinical Trials Logo

Clinical Trial Summary

The objective of this clinical investigation is to determine the performance and safety profile of NU-MAX® when used as a topical hemostat for oozing bleedings encountered during intracranial procedures, in which control of bleeding by conventional hemostatic techniques is either ineffective or impractical.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04953949
Study type Interventional
Source 3-D Matrix Europe SAS
Contact
Status Completed
Phase N/A
Start date August 6, 2021
Completion date November 4, 2023